DENALI THERAPEUTICS IN
29.79
07-11月-24 15:23:56
15 分の遅延
株式
+0.24
+0.81%
本日の幅
29.02 - 31.41
ISIN
N/A
ソース
NASDAQ
-
Denali Therapeutics Announces FDA Clinical Hold on DNL919 Investigational New Drug (IND) Application
13 1 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
10 1 2022 08:00:03 提供 Nasdaq GlobeNewswire
-
17 11 2021 08:30:00 提供 Nasdaq GlobeNewswire
-
Denali Therapeutics Reports Third Quarter 2021 Financial Results and Business Highlights
04 11 2021 16:01:00 提供 Nasdaq GlobeNewswire
-
06 10 2021 16:01:00 提供 Nasdaq GlobeNewswire
-
Denali Therapeutics Appoints Katie Peng as Chief Commercial Officer
27 9 2021 09:00:00 提供 Nasdaq GlobeNewswire
-
Denali Therapeutics Announces Initiation of Phase 1b Study of EIF2B Activator DNL343 in ALS
09 9 2021 09:00:01 提供 Nasdaq GlobeNewswire
-
Denali Therapeutics Announces Publication in Cell on New Approach to Treat FTD-GRN
26 8 2021 11:00:00 提供 Nasdaq GlobeNewswire
-
25 7 2021 11:05:00 提供 Nasdaq GlobeNewswire
-
15 7 2021 09:00:01 提供 Nasdaq GlobeNewswire
-
28 6 2021 08:00:00 提供 Nasdaq GlobeNewswire
-
Denali Therapeutics Reports First Quarter 2021 Financial Results and Business Highlights
03 5 2021 08:30:00 提供 Nasdaq GlobeNewswire
-
11 3 2021 08:30:00 提供 Nasdaq GlobeNewswire
-
Denali Therapeutics Reports Full Year 2020 Financial Results and Business Highlights
25 2 2021 16:01:01 提供 Nasdaq GlobeNewswire
-
12 2 2021 07:30:00 提供 Nasdaq GlobeNewswire
-
05 2 2021 09:00:00 提供 Nasdaq GlobeNewswire
-
Denali Therapeutics Announces Appointment of Nancy Thornberry to Board of Directors
11 1 2021 08:30:00 提供 Nasdaq GlobeNewswire
-
08 1 2021 08:30:00 提供 Nasdaq GlobeNewswire